Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management (NCT07776457)
Substance Use in Pregnancy- Optimizing Retention in Treatment by Maximizing Opportunities for Management
🩺 Plain-English Summary (8th-Grade Level)
Overdose is a national top-three leading cause of pregnancy-associated death, and maternal substance use disorder (SUD) accounts for an estimated $1.5 billion in healthcare spending each year. Treatment with medication and behavioral therapy lowers morbidity and overdose risk. However, studies have shown 55% to 80% of patients stop treatment within one year postpartum. Additionally, as a result of systemic inequities, historically marginalized patients are at greatest risk of overdose or death. We are conducting a study at WashU Medicine and University of Maryland, Baltimore clinics that offer prenatal care, addiction treatment, and extended postpartum support for patients facing the challenges of a SUD. Study participants will complete a structured screening and management of their social needs, and then will be randomly assigned to continue their usual care or to participate in a contingency management program, which provides incentives to continue treatment.
Who can join: Review the eligibility criteria below.
Location: Washington University — St Louis, Missouri
Age range: 18 Years
🧪 Interventions in This Study
- Contingency Management (BEHAVIORAL)
- Social Drivers of Health Screening (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Washington University — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (557) 234-9066
Email: melissa.mills@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pregnancy
- Mother and Infant Home Visiting Program Evaluation — New York, New York
- Maternal Stress and Blood Sugar Metabolization — Sioux Falls, South Dakota
- Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation — Chicago, Illinois
- A Multimedia Presentation to Augment the Informed Consent Process for Anesthesia for Patients Undergoing Scheduled Caesarian Delivery — Chicago, Illinois
- Effects of Increased Maternal Choline Intake on Child Cognitive Development — Ithaca, New York
- Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 — Ann Arbor, Michigan
Explore by condition: All Pregnancy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.